Axonics Modulation Technologies Secures $32,600,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9dfd4756-a2c9-4577-9e9c-bb5833c6bbe3
Date
3/26/2014
Company Name
Axonics Modulation Technologies
Mailing Address
16411 Scientific Way Irvine, CA 92618 USA
Company Description
Axonics, based in Irvine, Calif., is a privately held venture-backed pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
Website
http://www.axonicsmodulation.com
Transaction Type
Venture Equity
Transaction Amount
$32,600,000
Transaction Round
Series A
Proceeds Purposes
Proceeds from the financing will provide working capital to accelerate product development and fund a series of multi-center clinical studies to establish safety and efficacy of the company’s patented neuromodulation system.
M&A Terms
Venture Investor
Venture Investor
Venture Investor